Search

Author/Creator Salmonsson, Tomas

1. Individual Trade‐Offs Between Possible Benefits and Risks of Cancer Treatments: Results from a Stated Preference Study with Patients with Multiple Myeloma. (27th October 2017)

Authors:
Postmus, Douwe; Richard, Sarah; Bere, Nathalie; van Valkenhoef, Gert; Galinsky, Jayne; Low, Eric; Moulon, Isabelle; Mavris, Maria; Salmonsson, Tomas; Flores, Beatriz; Hillege, Hans; Pignatti, Francesco
Journal:
Oncologist
Issue:
Volume 23:Number 1(2018)
Page Start:
44
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

2. The EMA Review of Mylotarg (Gemtuzumab Ozogamicin) for the Treatment of Acute Myeloid Leukemia. (21st March 2019)

Authors:
Ali, Sahra; Dunmore, Helen‐Marie; Karres, Dominik; Hay, Justin L.; Salmonsson, Tomas; Gisselbrecht, Christian; Sarac, Sinan B.; Bjerrum, Ole W.; Hovgaard, Doris; Barbachano, Yolanda; Nagercoil, Nithyanandan; Pignatti, Francesco
Journal:
Oncologist
Issue:
Volume 24:Number 5(2019)
Page Start:
e171
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

Limit your search